Related Experiment Video

Updated: Aug 7, 2026

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
08:33

Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis

Published on: December 5, 2017

Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1

Lyubomir T Vassilev1, Christian Tovar, Shaoqing Chen

  • 1Departments of Discovery Oncology and Discovery Chemistry, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, NJ 07110, USA. lyubomir.vassilev@roche.com

Proceedings of the National Academy of Sciences of the United States of America
|July 5, 2006
PubMed

Insights

A novel inhibitor selectively targets cyclin-dependent kinase 1 (CDK1), halting cell division at mitosis. This CDK1 inhibition prevents premature cell division and induces apoptosis in tumor cells, showing potential for cancer therapy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Cyclin-dependent kinase 1 (CDK1) plays a critical role in cell division (mitosis).
  • The precise molecular functions of CDK1 are not fully understood.
  • CDK1 is essential for cell cycle progression.

Purpose of the Study:

  • To identify a selective small-molecule inhibitor of CDK1.
  • To investigate the molecular functions of CDK1 during mitosis.
  • To evaluate the therapeutic potential of CDK1 inhibitors in cancer.

Main Methods:

  • Development of a selective small-molecule inhibitor for CDK1.
  • Cell cycle analysis of human cells treated with the inhibitor.
  • Assessment of CDK1 activity and its effects on mitotic progression.
  • Evaluation of apoptosis induction in tumor cells upon prolonged inhibitor exposure.

Main Results:

  • The CDK1 inhibitor reversibly arrests human cells at the G(2)/M phase.
  • Effective synchronization of cells in early mitosis was achieved.
  • CDK1 activity was found to be necessary and sufficient for maintaining the mitotic state.
  • Inhibition prevented replication origin licensing and premature cytokinesis.
  • Prolonged CDK1 inhibition (over 24 hours) induced apoptosis in tumor cells.

Conclusions:

  • Selective CDK1 inhibition offers a novel strategy for cell cycle synchronization.
  • CDK1 activity is crucial for maintaining mitotic integrity.
  • Targeting CDK1 with small-molecule inhibitors demonstrates potential as a cancer therapeutic strategy due to its ability to induce apoptosis in tumor cells.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.